Measbio 0,5 ml Injection
PDF Leaflet Revision Date: 13 July 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation against measles.
Dosage (summary)
0.5 ml subcutaneously at 9 months, booster at 18 months; additional dose at 6 months for HIV positive patients.
Special Populations
- HIV positive patients
- Children with a history of convulsions
Pregnancy & Breastfeeding
Not to be given to pregnant women; effects on fetus unknown.
Key Drug Interactions
- Corticosteroids
- Immunosuppressive drugs
- Radiotherapy
Contraindications
- Active respiratory infection
- Acute infectious diseases
- Leukaemia
- Severe anaemia
- Severe renal impairment
- Decompensated heart disease
- Allergy to kanamycin or erythromycin
Common side effects
- Fever
- Burning at injection site
- Skin rash
- Allergic reactions
- Headache
Counselling Points
- Administer immediately after reconstitution
- Store reconstituted vaccine at 2-8u00b0C for up to 6 hours
- Monitor for anaphylaxis
Serious warnings
- Insufficient antibody response in immunosuppressed patients
- Not to be administered intravenously
Important Disclaimer
The Measbio 0,5 ml Injection professional information leaflet below is the property of The Biovac Institute and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
